Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 28

1.

Identification of internalizing human single-chain antibodies targeting brain tumor sphere cells.

Zhu X, Bidlingmaier S, Hashizume R, James CD, Berger MS, Liu B.

Mol Cancer Ther. 2010 Jul;9(7):2131-41. doi: 10.1158/1535-7163.MCT-09-1059. Epub 2010 Jun 29.

PMID:
20587664
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

MicroRNA-34a inhibits glioblastoma growth by targeting multiple oncogenes.

Li Y, Guessous F, Zhang Y, Dipierro C, Kefas B, Johnson E, Marcinkiewicz L, Jiang J, Yang Y, Schmittgen TD, Lopes B, Schiff D, Purow B, Abounader R.

Cancer Res. 2009 Oct 1;69(19):7569-76. doi: 10.1158/0008-5472.CAN-09-0529. Epub 2009 Sep 22.

PMID:
19773441
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Novel cationic lipid that delivers siRNA and enhances therapeutic effect in lung cancer cells.

Chen Y, Sen J, Bathula SR, Yang Q, Fittipaldi R, Huang L.

Mol Pharm. 2009 May-Jun;6(3):696-705. doi: 10.1021/mp800136v.

PMID:
19267451
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Identification of MCAM/CD146 as the target antigen of a human monoclonal antibody that recognizes both epithelioid and sarcomatoid types of mesothelioma.

Bidlingmaier S, He J, Wang Y, An F, Feng J, Barbone D, Gao D, Franc B, Broaddus VC, Liu B.

Cancer Res. 2009 Feb 15;69(4):1570-7. doi: 10.1158/0008-5472.CAN-08-1363. Epub 2009 Feb 3.

PMID:
19221091
[PubMed - indexed for MEDLINE]
Free PMC Article
5.

Human antibodies targeting cell surface antigens overexpressed by the hormone refractory metastatic prostate cancer cells: ICAM-1 is a tumor antigen that mediates prostate cancer cell invasion.

Conrad F, Zhu X, Zhang X, Chalkley RJ, Burlingame AL, Marks JD, Liu B.

J Mol Med (Berl). 2009 May;87(5):507-14. doi: 10.1007/s00109-009-0446-3. Epub 2009 Feb 14.

PMID:
19219419
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The promises and pitfalls of RNA-interference-based therapeutics.

Castanotto D, Rossi JJ.

Nature. 2009 Jan 22;457(7228):426-33. doi: 10.1038/nature07758. Review.

PMID:
19158789
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Enhancement of survivin gene downregulation and cell apoptosis by a novel combination: liposome microbubbles and ultrasound exposure.

Chen Z, Liang K, Liu J, Xie M, Wang X, Lü Q, Zhang J, Fang L.

Med Oncol. 2009 Dec;26(4):491-500. doi: 10.1007/s12032-008-9161-0. Epub 2009 Jan 7.

PMID:
19137432
[PubMed - indexed for MEDLINE]
8.

MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.

Yan D, Zhou X, Chen X, Hu DN, Dong XD, Wang J, Lu F, Tu L, Qu J.

Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1559-65. doi: 10.1167/iovs.08-2681. Epub 2008 Nov 21.

PMID:
19029026
[PubMed - indexed for MEDLINE]
Free Article
9.

miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells.

Li N, Fu H, Tie Y, Hu Z, Kong W, Wu Y, Zheng X.

Cancer Lett. 2009 Mar 8;275(1):44-53. doi: 10.1016/j.canlet.2008.09.035. Epub 2008 Nov 8.

PMID:
19006648
[PubMed - indexed for MEDLINE]
10.

An efficient and low immunostimulatory nanoparticle formulation for systemic siRNA delivery to the tumor.

Chono S, Li SD, Conwell CC, Huang L.

J Control Release. 2008 Oct 6;131(1):64-9. doi: 10.1016/j.jconrel.2008.07.006. Epub 2008 Jul 13.

PMID:
18674578
[PubMed - indexed for MEDLINE]
Free PMC Article
11.

Efficient oncogene silencing and metastasis inhibition via systemic delivery of siRNA.

Li SD, Chono S, Huang L.

Mol Ther. 2008 May;16(5):942-6. doi: 10.1038/mt.2008.51. Epub 2008 Mar 18.

PMID:
18388916
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Targeted drug delivery to mesothelioma cells using functionally selected internalizing human single-chain antibodies.

An F, Drummond DC, Wilson S, Kirpotin DB, Nishimura SL, Broaddus VC, Liu B.

Mol Cancer Ther. 2008 Mar;7(3):569-78. doi: 10.1158/1535-7163.MCT-07-2132. Epub 2008 Mar 4.

PMID:
18319332
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

The MAPK pathway in melanoma.

Fecher LA, Amaravadi RK, Flaherty KT.

Curr Opin Oncol. 2008 Mar;20(2):183-9. doi: 10.1097/CCO.0b013e3282f5271c. Review.

PMID:
18300768
[PubMed - indexed for MEDLINE]
14.

Anti-CD166 single chain antibody-mediated intracellular delivery of liposomal drugs to prostate cancer cells.

Roth A, Drummond DC, Conrad F, Hayes ME, Kirpotin DB, Benz CC, Marks JD, Liu B.

Mol Cancer Ther. 2007 Oct;6(10):2737-46.

PMID:
17938267
[PubMed - indexed for MEDLINE]
Free Article
15.

Tumor-targeted delivery of siRNA by self-assembled nanoparticles.

Li SD, Chen YC, Hackett MJ, Huang L.

Mol Ther. 2008 Jan;16(1):163-9. Epub 2007 Oct 9.

PMID:
17923843
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Primer extension-based method for the generation of a siRNA/miRNA expression vector.

Gou D, Zhang H, Baviskar PS, Liu L.

Physiol Genomics. 2007 Nov 14;31(3):554-62. Epub 2007 Sep 5.

PMID:
17804605
[PubMed - indexed for MEDLINE]
Free Article
17.

MicroRNA-34a functions as a potential tumor suppressor by inducing apoptosis in neuroblastoma cells.

Welch C, Chen Y, Stallings RL.

Oncogene. 2007 Jul 26;26(34):5017-22. Epub 2007 Feb 12.

PMID:
17297439
[PubMed - indexed for MEDLINE]
18.

Construction of human ScFv phage display library against ovarian tumor.

Xia J, Bi H, Yao Q, Qu S, Zong Y.

J Huazhong Univ Sci Technolog Med Sci. 2006;26(5):497-9.

PMID:
17219950
[PubMed - indexed for MEDLINE]
19.

Identification of clinically significant tumor antigens by selecting phage antibody library on tumor cells in situ using laser capture microdissection.

Ruan W, Sassoon A, An F, Simko JP, Liu B.

Mol Cell Proteomics. 2006 Dec;5(12):2364-73. Epub 2006 Sep 18.

PMID:
16982673
[PubMed - indexed for MEDLINE]
Free Article
20.

MicroRNA: biogenetic and functional mechanisms and involvements in cell differentiation and cancer.

Tsuchiya S, Okuno Y, Tsujimoto G.

J Pharmacol Sci. 2006 Aug;101(4):267-70. Review.

PMID:
16921236
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk